CYP 9.30% 23.5¢ cynata therapeutics limited

KILIAN KELLY INTERVIEW, page-6

  1. 1,070 Posts.
    lightbulb Created with Sketch. 546
    For those who aren't familiar with KILIAN KELLY, he's previous appointments in Australia include:
    - MESOBLAST (Vice President, Regulatory & Clinical)
    - BIOTA (Senior Director, Drug Development)
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.